Simon Englund

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jag är doktorand och projektsamordnare vid Institutionen för Klinisk Neurovetenskap, Karolinska Institutet, Stockholm, inom området multipel skleros (MS). Min forskning fokuserar främst på att identifiera prediktorer för och konsekvenser av fatigue inom MS, samt att jämföra olika behandlingsalternativ för fatigue, främst genom epidemiologiska studier

Artiklar

Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024;95(11):jnnp-2024-333595-1020
Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy
Englund S; Frisell T; Qu Y; Gandhi K; Hulten A; Kierkegaard M; Piehl F; Longinetti E
Article: ANNALS OF NEUROLOGY. 2024;:678-693
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
Piehl F; Alping P; Virtanen S; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Mellergard J; Nilsson P; Olsson T; Salzer J; Svenningsson A; Frisell T
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024;95(2):134-141
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
Longinetti E; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould AM; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Olsson T; Piehl F; Frisell T
Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(6):731-740
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
Fink K; Gorczyca A; Alping P; Englund S; Farmand S; Langer-Gould AM; Piehl F; McKay K; Frisell T; Razaz N
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023;70:104481
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
Englund S; Kierkegaard M; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Olsson T; Longinetti E; Frisell T; Piehl F
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2022;68:104106
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial
Englund S; Piehl F; Kierkegaard M
Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(9):1449-1458
COVID-19 clinical outcomes and DMT of MS patients and population-based controls
Longinetti E; Bower H; McKay KA; Englund S; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Mellergard J; Olsson T; Piehl F; Frisell T
Article: MULTIPLE SCLEROSIS JOURNAL. 2022;28(4):632-641
Risk of depression in multiple sclerosis across disease-modifying therapies
Longinetti E; Frisell T; Englund S; Reutfors J; Fang F; Piehl F
Article: AGE AND AGEING. 2021;50(2):480-487
Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study
Wu W; Xu W; Englund S; Shang Y; Pan K-Y; Rizzuto D

Alla övriga publikationer

Letter: JAMA NETWORK OPEN. 2021;4(12):e2136697
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden
McKay KA; Piehl F; Englund S; He A; Langer-Gould A; Hillert J; Frisell T

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI